Wednesday, July 8, 2026

pharma · Metastatic castration-resistant prostate cancer. · short-term treatment of insomnia

Orion Laboratories Pty

Orion Laboratories Pty trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.

Baton Rouge, USA HQ
2008 Founded
52 Employees
TGA registrant Type
Company details
Status
Public
HQ
Baton Rouge, USA
Founded
2008
Employees
52
Programs
9
Drugs
20
Patents
0
Intelligence · Clinical Trials

Orion Laboratories Pty clinical trials

Registry index of 9 ClinicalTrials.gov studies linked to Orion Laboratories Pty programs — each row shows trial ID, program name, phase, status, and indication.

Orion Laboratories Pty trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Orion Laboratories Pty.

  1. 3135004 — Phase 1

    Clinical update
  2. 3135003 — Phase 1

    Clinical update
  3. 3137001 — Phase 1

    Clinical update
  4. 3134003 — Phase 2

    Clinical update
  5. 3133004 — Phase 2

    Clinical update
  6. 3133003 — Phase 2

    Clinical update
  7. 3124001 — Phase 2

    Clinical update
  8. Arazasetron besylate — Phase 2

    Clinical update

Trial registry

9 studies